Hasan Fehmi Küçük
Hasan Fehmi Küçük has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
- Hasan Ediz Sikar
Department of General Surgery, University of Health Sciences, Kartal Dr. Lutfi Kirdar Training and Research Hospital, 34890, Istanbul, Turkey
6 shared publications - Cemal Hacıalioğlu
Istanbul Kartal Dr. Lutfi Kirdar City Hospital, Turkey
4 shared publications - Kenan Çetin
Department of General Surgery, Faculty of Medicine, Çanakkale Onsekiz Mart University, Canakkale, Turkey
4 shared publications - Gökay Çetinkaya
Kartal Dr. Lütfi Kırdar City Hospital, 34862 İstanbul, Türkiye
3 shared publications - Levent Kaptanoglu
Dr. Lütfi Kirdar Kartal Training and Research Hospital, Istanbul, Turkey
3 shared publications - Mehmet Karahan
Department of General Surgery, University of Health Sciences, Kartal Lutfi Kirdar City Hospital, Istanbul, Turkey
3 shared publications
Latest Publications
- Open Access
- 15 October 2026
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 56 (5) , 1476-1487
Patterns and clinical outcomes of necrotizing soft tissue infections: a 5-year single-center cohort study
Background/aim: Necrotizing soft tissue infections are uncommon but rapidly lethal, and their perineal form, Fournier’s gangrene, is most often referred for reconstruction. Whether routine admission findings identify the highest-risk patients more accurately than severity scores remains uncertain, and whether sodium-glucose cotransporter-2 (SGLT-2) inhibitors, which are widely used in patients with diabetes, influence clinical outcomes also remains unclear. Materials and methods: We retrospectively studied consecutive adults with necrotizing soft tissue infection at a tertiary referral center over 5 years. A subcohort of 70 patients who underwent plastic and reconstructive surgery was identified within the full institutional cohort of 137. Admission findings were compared according to in-hospital mortality, the ability of severity scores to discriminate mortality was evaluated, and, among patients with diabetes, SGLT-2 inhibitor exposure was explored in relation to clinical outcomes. Results: Fournier’s gangrene predominated (85.7%), and 85.7% had diabetes. In-hospital mortality was 18.6% in the reconstructive subcohort and 21.9% in the overall institutional cohort; 41.4% of patients required intensive care, and the median hospital stay was 18 days. Lower admission serum albumin levels, a higher C-reactive protein-to-albumin ratio, and septic shock were associated with inhospital mortality (all p < 0.001), whereas the LRINEC and SIARI scores and the neutrophil-to-lymphocyte ratio did not discriminate mortality. After early radical debridement, the resulting defects were reconstructed according to the reconstructive ladder, ranging from skin grafting to local/regional and free flap reconstruction. Among patients with diabetes, SGLT-2 inhibitor exposure was not associated with in-hospital mortality (15.2% versus 19.6%; p = 0.78) or intensive care unit admission. Conclusion: Severity scores aid diagnosis, whereas admission biochemical and physiological parameters provide prognostic information, helping identify patients at the highest risk who may benefit from early triage. Once debridement achieved source control, flaps were the mainstay for closing the perineogenital defects. Because our analysis included only patients who had already developed the disease, it addresses outcomes rather than incidence or causation. SGLT-2 inhibitor exposure was not associated with worse outcomes; however, this hypothesis-generating finding does not establish safety.
- 15 October 2026
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 56 (5) , 1476-1487
Open AccessPatterns and clinical outcomes of necrotizing soft tissue infections: a 5-year single-center cohort study
Background/aim: Necrotizing soft tissue infections are uncommon but rapidly lethal, and their perineal form, Fournier’s gangrene, is most often referred for reconstruction. Whether routine admission findings identify the highest-risk patients more accurately than severity scores remains uncertain, and whether sodium-glucose cotransporter-2 (SGLT-2) inhibitors, which are widely used in patients with diabetes, influence clinical outcomes also remains unclear. Materials and methods: We retrospectively studied consecutive adults with necrotizing soft tissue infection at a tertiary referral center over 5 years. A subcohort of 70 patients who underwent plastic and reconstructive surgery was identified within the full institutional cohort of 137. Admission findings were compared according to in-hospital mortality, the ability of severity scores to discriminate mortality was evaluated, and, among patients with diabetes, SGLT-2 inhibitor exposure was explored in relation to clinical outcomes. Results: Fournier’s gangrene predominated (85.7%), and 85.7% had diabetes. In-hospital mortality was 18.6% in the reconstructive subcohort and 21.9% in the overall institutional cohort; 41.4% of patients required intensive care, and the median hospital stay was 18 days. Lower admission serum albumin levels, a higher C-reactive protein-to-albumin ratio, and septic shock were associated with inhospital mortality (all p < 0.001), whereas the LRINEC and SIARI scores and the neutrophil-to-lymphocyte ratio did not discriminate mortality. After early radical debridement, the resulting defects were reconstructed according to the reconstructive ladder, ranging from skin grafting to local/regional and free flap reconstruction. Among patients with diabetes, SGLT-2 inhibitor exposure was not associated with in-hospital mortality (15.2% versus 19.6%; p = 0.78) or intensive care unit admission. Conclusion: Severity scores aid diagnosis, whereas admission biochemical and physiological parameters provide prognostic information, helping identify patients at the highest risk who may benefit from early triage. Once debridement achieved source control, flaps were the mainstay for closing the perineogenital defects. Because our analysis included only patients who had already developed the disease, it addresses outcomes rather than incidence or causation. SGLT-2 inhibitor exposure was not associated with worse outcomes; however, this hypothesis-generating finding does not establish safety.
- Open Access
Incidental Gallbladder Cancer After Cholecystectomy for Presumed Benign Biliary Disease: A Sixteen-Year Retrospective Cohort Study from a Tertiary Referral Center
Background and Objectives: Incidental gallbladder cancer (IGBC) is an uncommon but clinically important diagnosis after cholecystectomy for presumed benign biliary disease. This study aimed to determine the incidence of invasive IGBC in a large cholecystectomy cohort and to describe its clinicopathological profile, stage-specific management pathway, and exploratory univariable survival associations. Materials and Methods: We retrospectively reviewed all cholecystectomies performed between January 2010 and December 2025 at a tertiary referral center (n = 19,798). Patients with known preoperative gallbladder cancer and those with incomplete data precluding reliable staging or survival assessment were excluded. Only invasive IGBC was analyzed; dysplasia and carcinoma in situ were excluded a priori. Overall survival (OS) was defined from index surgery to death from any cause, and disease-free survival (DFS) was assessed in patients with non-metastatic disease at baseline. Survival was estimated using Kaplan–Meier methods, and associations with survival outcomes were explored using univariable Cox regression. Results: IGBC was identified in 43 patients (0.22%). Adenocarcinoma predominated, pT2 was the most frequent pathological stage, and 11 patients (25.6%) had pT3–T4 disease. Staged re-resection was performed in 12 patients (27.9%). Median OS was 48.0 months (95% CI, 34.0–62.0), and median DFS in the M0 cohort was 80.0 months (95% CI, 9.5–150.5). The 2-, 4-, and 6-year OS rates were 78.2%, 48.3%, and 38.8%, respectively; the corresponding DFS rates were 70.4%, 59.3%, and 50.8%. In exploratory univariable analyses, pathological T stage showed the most consistent unadjusted association with OS and DFS, whereas margin positivity, perineural invasion, lymphovascular invasion, and increasing tumor size were associated with worse DFS. Conclusions: Although rare, IGBC may present with advanced pathological features despite presumed benign disease. These findings support meticulous pathological assessment, structured postoperative staging, and risk-adapted multidisciplinary management. Given the limited sample size and exploratory, unadjusted analyses, survival associations should be interpreted cautiously.
Open AccessIncidental Gallbladder Cancer After Cholecystectomy for Presumed Benign Biliary Disease: A Sixteen-Year Retrospective Cohort Study from a Tertiary Referral Center
Background and Objectives: Incidental gallbladder cancer (IGBC) is an uncommon but clinically important diagnosis after cholecystectomy for presumed benign biliary disease. This study aimed to determine the incidence of invasive IGBC in a large cholecystectomy cohort and to describe its clinicopathological profile, stage-specific management pathway, and exploratory univariable survival associations. Materials and Methods: We retrospectively reviewed all cholecystectomies performed between January 2010 and December 2025 at a tertiary referral center (n = 19,798). Patients with known preoperative gallbladder cancer and those with incomplete data precluding reliable staging or survival assessment were excluded. Only invasive IGBC was analyzed; dysplasia and carcinoma in situ were excluded a priori. Overall survival (OS) was defined from index surgery to death from any cause, and disease-free survival (DFS) was assessed in patients with non-metastatic disease at baseline. Survival was estimated using Kaplan–Meier methods, and associations with survival outcomes were explored using univariable Cox regression. Results: IGBC was identified in 43 patients (0.22%). Adenocarcinoma predominated, pT2 was the most frequent pathological stage, and 11 patients (25.6%) had pT3–T4 disease. Staged re-resection was performed in 12 patients (27.9%). Median OS was 48.0 months (95% CI, 34.0–62.0), and median DFS in the M0 cohort was 80.0 months (95% CI, 9.5–150.5). The 2-, 4-, and 6-year OS rates were 78.2%, 48.3%, and 38.8%, respectively; the corresponding DFS rates were 70.4%, 59.3%, and 50.8%. In exploratory univariable analyses, pathological T stage showed the most consistent unadjusted association with OS and DFS, whereas margin positivity, perineural invasion, lymphovascular invasion, and increasing tumor size were associated with worse DFS. Conclusions: Although rare, IGBC may present with advanced pathological features despite presumed benign disease. These findings support meticulous pathological assessment, structured postoperative staging, and risk-adapted multidisciplinary management. Given the limited sample size and exploratory, unadjusted analyses, survival associations should be interpreted cautiously.
- 9 April 2026
- Published by Wiley in Clinical Transplantation
- Vol. 40 (4) , e70532
Erector Spinae Plane Block Versus Transmuscular Quadratus Lumborum Block for Postoperative Analgesia in Kidney Transplantation: A Prospective Randomised Controlled Trial
Background: Postoperative pain management in kidney transplant recipients is challenging due to altered drug pharmacokinetics and the need to minimize opioid related adverse effects. Ultrasound guided erector spinae plane block (ESPB) and transmuscular quadratus lumborum block (TMQLB) have emerged as effective components of multimodal analgesia; however, comparative data in kidney transplantation are limited. Methods: In this prospective, single‐blind, randomized controlled trial, 63 adult patients undergoing elective living donor kidney transplantation were allocated to ESPB ( n = 21), TMQLB ( n = 21), or control ( n = 21) groups. Patients in the block groups received ultrasound guided ESPB or TMQLB following induction of general anesthesia, while the control group received standard analgesia alone. Postoperative pain intensity was assessed using visual analog scale (VAS) scores during the first 24 h. Total tramadol consumption, time to first analgesic requirement, need for rescue analgesia, adverse effects, and hemodynamic parameters were recorded. Results: Both ESPB and TMQLB groups demonstrated significantly lower VAS scores at all postoperative time points compared with the control group ( p < 0.001). Total tramadol consumption was significantly reduced, and the time to first tramadol requirement was significantly prolonged in the block groups versus control ( p < 0.001). No significant differences were observed between ESPB and TMQLB with respect to pain scores or total tramadol consumption. Hemodynamic parameters remained stable, and no block related complications were observed. Conclusions: In kidney transplant recipients, both ESPB and TMQLB provide effective and hemodynamically stable opioid‐sparing postoperative analgesia. The comparable efficacy of these techniques allows flexibility in block selection based on patient characteristics and institutional experience.
- 9 April 2026
- Published by Wiley in Clinical Transplantation
- Vol. 40 (4) , e70532
Erector Spinae Plane Block Versus Transmuscular Quadratus Lumborum Block for Postoperative Analgesia in Kidney Transplantation: A Prospective Randomised Controlled Trial
Background: Postoperative pain management in kidney transplant recipients is challenging due to altered drug pharmacokinetics and the need to minimize opioid related adverse effects. Ultrasound guided erector spinae plane block (ESPB) and transmuscular quadratus lumborum block (TMQLB) have emerged as effective components of multimodal analgesia; however, comparative data in kidney transplantation are limited. Methods: In this prospective, single‐blind, randomized controlled trial, 63 adult patients undergoing elective living donor kidney transplantation were allocated to ESPB ( n = 21), TMQLB ( n = 21), or control ( n = 21) groups. Patients in the block groups received ultrasound guided ESPB or TMQLB following induction of general anesthesia, while the control group received standard analgesia alone. Postoperative pain intensity was assessed using visual analog scale (VAS) scores during the first 24 h. Total tramadol consumption, time to first analgesic requirement, need for rescue analgesia, adverse effects, and hemodynamic parameters were recorded. Results: Both ESPB and TMQLB groups demonstrated significantly lower VAS scores at all postoperative time points compared with the control group ( p < 0.001). Total tramadol consumption was significantly reduced, and the time to first tramadol requirement was significantly prolonged in the block groups versus control ( p < 0.001). No significant differences were observed between ESPB and TMQLB with respect to pain scores or total tramadol consumption. Hemodynamic parameters remained stable, and no block related complications were observed. Conclusions: In kidney transplant recipients, both ESPB and TMQLB provide effective and hemodynamically stable opioid‐sparing postoperative analgesia. The comparable efficacy of these techniques allows flexibility in block selection based on patient characteristics and institutional experience.
- Open Access
- 11 February 2026
- Published by MDPI AG in Preprints.org
Incidental Gallbladder Carcinoma Detected in Routine Cholecystectomy Specimens: A Fifteen-Year Evaluation from a Tertiary Referral Center
Background/Objectives: Incidental gallbladder cancer (IGBC) is an uncommon but clinically important malignancy, typically diagnosed unexpectedly after cholecystectomy performed for benign indications. Despite its incidental nature, IGBC may present with advanced pathological features and unfavorable outcomes. This study aimed to evaluate the incidence, clinicopathological characteristics, surgical management, and prognostic factors of IGBC in a large cholecystectomy cohort from a tertiary referral center. Methods: A retrospective analysis was performed on 19,798 cholecystectomy procedures conducted between January 2010 and December 2025. Patients with a preoperative diagnosis of gallbladder cancer or incomplete clinical or pathological data were excluded. Only cases with invasive incidental gallbladder cancer (IGBC) were included, whereas dysplasia and carcinoma in situ were excluded. Demographic, clinical, surgical, pathological, and survival data were systematically collected. Results: Incidental gallbladder cancer was identified in 43 patients (0.22%). The mean age was 71.4 ± 9.9 years, and 74.4% were female. Gallstones were present in 88.4% of patients. Adenocarcinoma was the predominant histology (90.7%), and pT2 disease was the most common stage (41.9%), while 25.6% had advanced-stage tumors (pT3–T4). Median OS was 26.0 months, and median DFS was 25.5 months in non-metastatic patients. Pathological T stage was significantly associated with both OS and DFS. Advanced T stage, positive surgical margins, perineural invasion, lymphovascular invasion, and increasing tumor size were significantly associated with worse DFS. Re-resection rates were limited, mainly due to advanced age and comorbidities. Conclusion: Although incidental gallbladder cancer is rare, it leads to clinically and oncologically significant outcomes. In this study, pathological T stage emerged as a key prognostic factor influencing both overall survival and disease-free survival. In addition, perineural invasion, lymphovascular invasion, and positive surgical margins were identified as the main pathological factors adversely affecting disease-free survival.
- 11 February 2026
- Published by MDPI AG in Preprints.org
Open AccessIncidental Gallbladder Carcinoma Detected in Routine Cholecystectomy Specimens: A Fifteen-Year Evaluation from a Tertiary Referral Center
Background/Objectives: Incidental gallbladder cancer (IGBC) is an uncommon but clinically important malignancy, typically diagnosed unexpectedly after cholecystectomy performed for benign indications. Despite its incidental nature, IGBC may present with advanced pathological features and unfavorable outcomes. This study aimed to evaluate the incidence, clinicopathological characteristics, surgical management, and prognostic factors of IGBC in a large cholecystectomy cohort from a tertiary referral center. Methods: A retrospective analysis was performed on 19,798 cholecystectomy procedures conducted between January 2010 and December 2025. Patients with a preoperative diagnosis of gallbladder cancer or incomplete clinical or pathological data were excluded. Only cases with invasive incidental gallbladder cancer (IGBC) were included, whereas dysplasia and carcinoma in situ were excluded. Demographic, clinical, surgical, pathological, and survival data were systematically collected. Results: Incidental gallbladder cancer was identified in 43 patients (0.22%). The mean age was 71.4 ± 9.9 years, and 74.4% were female. Gallstones were present in 88.4% of patients. Adenocarcinoma was the predominant histology (90.7%), and pT2 disease was the most common stage (41.9%), while 25.6% had advanced-stage tumors (pT3–T4). Median OS was 26.0 months, and median DFS was 25.5 months in non-metastatic patients. Pathological T stage was significantly associated with both OS and DFS. Advanced T stage, positive surgical margins, perineural invasion, lymphovascular invasion, and increasing tumor size were significantly associated with worse DFS. Re-resection rates were limited, mainly due to advanced age and comorbidities. Conclusion: Although incidental gallbladder cancer is rare, it leads to clinically and oncologically significant outcomes. In this study, pathological T stage emerged as a key prognostic factor influencing both overall survival and disease-free survival. In addition, perineural invasion, lymphovascular invasion, and positive surgical margins were identified as the main pathological factors adversely affecting disease-free survival.
- 26 January 2026
- Published by Wolters Kluwer Health in Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
- Vol. 36 (3)
Management of Iatrogenic Colonoscopic Perforations: A 5-Year Retrospective Analysis of Predictive Factors and Outcomes With Emphasis on Endoscopic Clip Closure
Background: Iatrogenic colonic perforation (ICP) is a rare but serious complication of colonoscopy. Its incidence varies according to whether the procedure is diagnostic or therapeutic. Although surgery has traditionally been the cornerstone of treatment, advances in endoscopic techniques—particularly clip application—have provided less invasive alternatives. This study aimed to present the clinical characteristics, management strategies, and outcomes of ICP in a high-volume tertiary center, with a particular focus on the efficacy and limitations of endoscopic clip closure. Methods: In this retrospective study, all patients diagnosed with ICP between 2019 and 2024 at Kartal Dr. Lutfi Kirdar City Hospital were evaluated. Among 87,526 colonoscopies performed during this period, 42 patients with ICP were included. Patients were classified according to whether colonoscopy was performed for diagnostic or therapeutic indications. Endoscopic clip closure was attempted in 14 patients and was successful in 8 of them (57.1%). Surgical intervention was performed in 34 patients, either after failed endoscopic management or as the primary treatment. Results: ICP developed more frequently during diagnostic procedures (69%). The sigmoid colon (57.1%) was the most common site of perforation, and most perforations were intraperitoneal (81%). Baseline demographic and clinical characteristics did not differ significantly between the diagnostic and therapeutic indication groups ( P >0.05). Successful endoscopic clip closure was associated with early diagnosis, good bowel preparation, and perforation size <2 cm. Patients treated endoscopically had shorter times to oral intake and shorter hospital stays compared with those treated surgically. Conclusions: Endoscopic clip application is an effective treatment option for carefully selected ICP cases with early recognition, favorable local conditions, and small, localized defects. However, surgery remains essential in large perforations, delayed diagnoses, or when clip closure fails. Our findings provide real-world data on the role and limitations of standard clip closure in a resource-limited tertiary center and support guideline-based, individualized decision-making for ICP management.
- 26 January 2026
- Published by Wolters Kluwer Health in Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
- Vol. 36 (3)
Management of Iatrogenic Colonoscopic Perforations: A 5-Year Retrospective Analysis of Predictive Factors and Outcomes With Emphasis on Endoscopic Clip Closure
Background: Iatrogenic colonic perforation (ICP) is a rare but serious complication of colonoscopy. Its incidence varies according to whether the procedure is diagnostic or therapeutic. Although surgery has traditionally been the cornerstone of treatment, advances in endoscopic techniques—particularly clip application—have provided less invasive alternatives. This study aimed to present the clinical characteristics, management strategies, and outcomes of ICP in a high-volume tertiary center, with a particular focus on the efficacy and limitations of endoscopic clip closure. Methods: In this retrospective study, all patients diagnosed with ICP between 2019 and 2024 at Kartal Dr. Lutfi Kirdar City Hospital were evaluated. Among 87,526 colonoscopies performed during this period, 42 patients with ICP were included. Patients were classified according to whether colonoscopy was performed for diagnostic or therapeutic indications. Endoscopic clip closure was attempted in 14 patients and was successful in 8 of them (57.1%). Surgical intervention was performed in 34 patients, either after failed endoscopic management or as the primary treatment. Results: ICP developed more frequently during diagnostic procedures (69%). The sigmoid colon (57.1%) was the most common site of perforation, and most perforations were intraperitoneal (81%). Baseline demographic and clinical characteristics did not differ significantly between the diagnostic and therapeutic indication groups ( P >0.05). Successful endoscopic clip closure was associated with early diagnosis, good bowel preparation, and perforation size <2 cm. Patients treated endoscopically had shorter times to oral intake and shorter hospital stays compared with those treated surgically. Conclusions: Endoscopic clip application is an effective treatment option for carefully selected ICP cases with early recognition, favorable local conditions, and small, localized defects. However, surgery remains essential in large perforations, delayed diagnoses, or when clip closure fails. Our findings provide real-world data on the role and limitations of standard clip closure in a resource-limited tertiary center and support guideline-based, individualized decision-making for ICP management.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (10)
Hemorrhoidectomy vs. non-Doppler-guided hemorrhoidal artery ligation
SUMMARY OBJECTIVE: Hemorrhoidal disease is one of the most prevalent benign anorectal conditions, and the optimal surgical approach for higher-grade disease remains debated. Conventional excisional hemorrhoidectomy is durable but painful, whereas hemorrhoidal artery ligation with mucopexy is a minimally invasive alternative that aims to reduce morbidity. Although hemorrhoidal artery ligation was originally described as a Doppler-guided procedure, accumulating evidence has questioned whether intraoperative Doppler localization is essential, supporting fixed-position suture ligation as a simpler alternative. We compared conventional hemorrhoidectomy with non-Doppler hemorrhoidal artery ligation combined with mucopexy with respect to perioperative parameters and long-term patient-reported outcomes. METHODS: This single-center retrospective study included patients who underwent conventional hemorrhoidectomy or non-Doppler hemorrhoidal artery ligation combined with mucopexy for hemorrhoidal disease between June 2023 and December 2024. The hemorrhoidal artery ligation combined with mucopexy technique consisted of a full-thickness Z-suture placed approximately 4 cm proximal to the dentate line for arterial ligation, followed by a running mucopexy of four to six mucosal–submucosal bites at 5-mm intervals down to 5 mm above the dentate line, applied to each of the three classical anatomical hemorrhoidal positions (3, 7, and 11 o’clock). Demographic and perioperative data were obtained by chart review. Postoperative outcomes were assessed by a structured telephone interview conducted blinded to the operative technique, using the Hemorrhoidal Disease Symptom Score, the Short Health Scale for Hemorrhoidal Disease, a 0–10 patient satisfaction score, the Visual Analogue Scale for pain, and the Vaizey incontinence score. Recurrence was defined as the patient’s self-reported perception of a symptomatic anal lump and was not confirmed by physical examination. To account for the imbalance in hemorrhoid grade, multivariable logistic regression and a subgroup analysis restricted to grade 3 disease were performed, and effect estimates are reported with 95%CIs. RESULTS: Of 185 patients operated during the study period, 34 were excluded, leaving 151 patients (62 hemorrhoidectomy, 89 hemorrhoidal artery ligation combined with mucopexy). The groups were comparable in sex, age, American Society of Anesthesiologists class, and smoking status (all p>0.05). Hemorrhoid grade distribution differed significantly (p<0.001), with grade 2 disease present only in the hemorrhoidectomy group. Hospital stay was shorter after hemorrhoidal artery ligation combined with mucopexy (0.8±0.4 vs. 1.1±0.6 days; p=0.001). Over a mean follow-up of approximately 29 months, postoperative bleeding, tenesmus, Visual Analogue Scale pain, Vaizey score, patient satisfaction, and Hemorrhoidal Disease Symptom Score did not differ significantly between groups. Recurrence was numerically higher after hemorrhoidal artery ligation combined with mucopexy (25.8 vs. 12.9%; OR 2.35, 95%CI 0.97–5.68) but did not reach statistical significance (p=0.083), and the study was underpowered for this endpoint (post-hoc power 51.8%). The direction of the association persisted after adjustment (aOR 2.21, 95%CI 0.91–5.38) and in the grade 3 subgroup (24.0 vs. 12.8%; OR 2.15, 95%CI 0.73–6.31). Quality of life measured by Short Health Scale for Hemorrhoidal Disease was significantly better (lower) in the hemorrhoidectomy group (6.3±4.3 vs. 8.7±3.9; p<0.001). CONCLUSION: Both techniques achieved comparable symptom control, pain, continence, and satisfaction at long-term follow-up. Non-Doppler hemorrhoidal artery ligation combined with mucopexy offered a shorter hospital stay, while hemorrhoidectomy was associated with better disease-specific quality of life and a numerically lower recurrence rate that persisted after adjustment for hemorrhoid grade but did not reach statistical significance in an underpowered comparison. The results indicate that omission of the Doppler transducer does not compromise the long-term outcomes of hemorrhoidal artery ligation with mucopexy and support an individualized approach to technique selection.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (10)
Open AccessHemorrhoidectomy vs. non-Doppler-guided hemorrhoidal artery ligation
SUMMARY OBJECTIVE: Hemorrhoidal disease is one of the most prevalent benign anorectal conditions, and the optimal surgical approach for higher-grade disease remains debated. Conventional excisional hemorrhoidectomy is durable but painful, whereas hemorrhoidal artery ligation with mucopexy is a minimally invasive alternative that aims to reduce morbidity. Although hemorrhoidal artery ligation was originally described as a Doppler-guided procedure, accumulating evidence has questioned whether intraoperative Doppler localization is essential, supporting fixed-position suture ligation as a simpler alternative. We compared conventional hemorrhoidectomy with non-Doppler hemorrhoidal artery ligation combined with mucopexy with respect to perioperative parameters and long-term patient-reported outcomes. METHODS: This single-center retrospective study included patients who underwent conventional hemorrhoidectomy or non-Doppler hemorrhoidal artery ligation combined with mucopexy for hemorrhoidal disease between June 2023 and December 2024. The hemorrhoidal artery ligation combined with mucopexy technique consisted of a full-thickness Z-suture placed approximately 4 cm proximal to the dentate line for arterial ligation, followed by a running mucopexy of four to six mucosal–submucosal bites at 5-mm intervals down to 5 mm above the dentate line, applied to each of the three classical anatomical hemorrhoidal positions (3, 7, and 11 o’clock). Demographic and perioperative data were obtained by chart review. Postoperative outcomes were assessed by a structured telephone interview conducted blinded to the operative technique, using the Hemorrhoidal Disease Symptom Score, the Short Health Scale for Hemorrhoidal Disease, a 0–10 patient satisfaction score, the Visual Analogue Scale for pain, and the Vaizey incontinence score. Recurrence was defined as the patient’s self-reported perception of a symptomatic anal lump and was not confirmed by physical examination. To account for the imbalance in hemorrhoid grade, multivariable logistic regression and a subgroup analysis restricted to grade 3 disease were performed, and effect estimates are reported with 95%CIs. RESULTS: Of 185 patients operated during the study period, 34 were excluded, leaving 151 patients (62 hemorrhoidectomy, 89 hemorrhoidal artery ligation combined with mucopexy). The groups were comparable in sex, age, American Society of Anesthesiologists class, and smoking status (all p>0.05). Hemorrhoid grade distribution differed significantly (p<0.001), with grade 2 disease present only in the hemorrhoidectomy group. Hospital stay was shorter after hemorrhoidal artery ligation combined with mucopexy (0.8±0.4 vs. 1.1±0.6 days; p=0.001). Over a mean follow-up of approximately 29 months, postoperative bleeding, tenesmus, Visual Analogue Scale pain, Vaizey score, patient satisfaction, and Hemorrhoidal Disease Symptom Score did not differ significantly between groups. Recurrence was numerically higher after hemorrhoidal artery ligation combined with mucopexy (25.8 vs. 12.9%; OR 2.35, 95%CI 0.97–5.68) but did not reach statistical significance (p=0.083), and the study was underpowered for this endpoint (post-hoc power 51.8%). The direction of the association persisted after adjustment (aOR 2.21, 95%CI 0.91–5.38) and in the grade 3 subgroup (24.0 vs. 12.8%; OR 2.15, 95%CI 0.73–6.31). Quality of life measured by Short Health Scale for Hemorrhoidal Disease was significantly better (lower) in the hemorrhoidectomy group (6.3±4.3 vs. 8.7±3.9; p<0.001). CONCLUSION: Both techniques achieved comparable symptom control, pain, continence, and satisfaction at long-term follow-up. Non-Doppler hemorrhoidal artery ligation combined with mucopexy offered a shorter hospital stay, while hemorrhoidectomy was associated with better disease-specific quality of life and a numerically lower recurrence rate that persisted after adjustment for hemorrhoid grade but did not reach statistical significance in an underpowered comparison. The results indicate that omission of the Doppler transducer does not compromise the long-term outcomes of hemorrhoidal artery ligation with mucopexy and support an individualized approach to technique selection.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (5) , e20252235
Evaluation of routine four-quadrant re-excision in patients undergoing breast-conserving surgery
SUMMARY OBJECTIVE: The aim of this study was to evaluate the contribution of routine four-quadrant re-excision performed during breast-conserving surgery in detecting de novo tumor foci and ensuring negative surgical margins in patients with breast cancer. METHODS: A retrospective analysis was conducted on 44 female patients who underwent breast-conserving surgery between April 2021 and April 2023. In all cases, routine re-excision was performed in the superior, inferior, medial, and lateral quadrants during the same operative session. Based on pathological findings, patients with additional tumor foci in the re-excision specimens were classified as Group 1, while those without were classified as Group 2. RESULTS: The mean age of the patients was 54.2±11.6 years, with an average follow-up period of 21.5±8.3 months. Additional tumor foci were identified in seven patients (15.9%). There were no statistically significant differences between the groups in terms of age, tumor size, hormone receptor status, or histopathological characteristics (p>0.05). CONCLUSION: Routine four-quadrant re-excision may aid in the identification of microscopic de novo tumor foci even when clear surgical margins are achieved. However, larger multicenter studies with longer follow-up periods are warranted to determine its potential impact on local recurrence and long-term outcomes.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (5) , e20252235
Open AccessEvaluation of routine four-quadrant re-excision in patients undergoing breast-conserving surgery
SUMMARY OBJECTIVE: The aim of this study was to evaluate the contribution of routine four-quadrant re-excision performed during breast-conserving surgery in detecting de novo tumor foci and ensuring negative surgical margins in patients with breast cancer. METHODS: A retrospective analysis was conducted on 44 female patients who underwent breast-conserving surgery between April 2021 and April 2023. In all cases, routine re-excision was performed in the superior, inferior, medial, and lateral quadrants during the same operative session. Based on pathological findings, patients with additional tumor foci in the re-excision specimens were classified as Group 1, while those without were classified as Group 2. RESULTS: The mean age of the patients was 54.2±11.6 years, with an average follow-up period of 21.5±8.3 months. Additional tumor foci were identified in seven patients (15.9%). There were no statistically significant differences between the groups in terms of age, tumor size, hormone receptor status, or histopathological characteristics (p>0.05). CONCLUSION: Routine four-quadrant re-excision may aid in the identification of microscopic de novo tumor foci even when clear surgical margins are achieved. However, larger multicenter studies with longer follow-up periods are warranted to determine its potential impact on local recurrence and long-term outcomes.
- Open Access
- 31 December 2025
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 41 (6) , 573-585
Patient-reported outcomes after hemorrhoid surgery: early results from a prospective, nationwide, real-world, cohort study on diverse approaches
Purpose: Real-world evidence comparing surgical techniques for symptomatic hemorrhoidal disease (HD) remains limited, despite the availability of multiple approaches. This study aimed to evaluate short-term, interim outcomes from a prospective, nationwide cohort study that compared the effectiveness of different operative techniques based on patient-reported outcome measures (PROMs) in patients with symptomatic HD.Methods: A prospective, nationwide cohort study was conducted at 20 tertiary care centers across Turkiye between July 2022 and July 2024. Adult patients aged 18 years or older with symptomatic HD (grades I–IV) who underwent surgery during this period were included. The choice of procedure was determined by the operating surgeon, and patients were categorized into excisional, fixative, and ablative groups according to the surgical approach used. The primary outcomes were changes in the Hemorrhoidal Disease Symptom Score, Short Health ScaleHD, visual analog scale for pain, and patient satisfaction, assessed from the preoperative period to postoperative day 7 and postoperative week 6.Results: The study included a total of 315 patients after excluding those who did not fulfil the inclusion criteria. Among them, 239 (78.9%) were male, with a mean age of 43.7±11.7 years. The distribution of patients across surgical groups was 207 (65.7%) in the excisional group, 30 (9.5%) in the fixative group, and 78 (24.8%) in the ablative group. All groups demonstrated significant improvements in PROM scores from preoperative to postoperative assessments. However, no statistically significant differences were observed between groups at any time point for PROM scores or for changes in PROM scores across consecutive evaluations (P≥0.05 for all comparisons). Urinary retention occurred more frequently, and hospital stays were longer in the fixative group (P=0.006 and P<0.001, respectively). The excisional group had a greater need for narcotic use and longer duration of use (P=0.003 and P<0.001, respectively).Conclusion: This real-world cohort study shows that all 3 surgical approaches are effective for HD, providing comparable short-term symptomatic relief and patient satisfaction. These techniques appear equally valid treatment options, and the choice of procedure may best be individualized based on patient-specific characteristics and surgeon preference.Trial registration: ClinicalTrials.gov identifier: NCT05429060
- 31 December 2025
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 41 (6) , 573-585
Open AccessPatient-reported outcomes after hemorrhoid surgery: early results from a prospective, nationwide, real-world, cohort study on diverse approaches
Purpose: Real-world evidence comparing surgical techniques for symptomatic hemorrhoidal disease (HD) remains limited, despite the availability of multiple approaches. This study aimed to evaluate short-term, interim outcomes from a prospective, nationwide cohort study that compared the effectiveness of different operative techniques based on patient-reported outcome measures (PROMs) in patients with symptomatic HD.Methods: A prospective, nationwide cohort study was conducted at 20 tertiary care centers across Turkiye between July 2022 and July 2024. Adult patients aged 18 years or older with symptomatic HD (grades I–IV) who underwent surgery during this period were included. The choice of procedure was determined by the operating surgeon, and patients were categorized into excisional, fixative, and ablative groups according to the surgical approach used. The primary outcomes were changes in the Hemorrhoidal Disease Symptom Score, Short Health ScaleHD, visual analog scale for pain, and patient satisfaction, assessed from the preoperative period to postoperative day 7 and postoperative week 6.Results: The study included a total of 315 patients after excluding those who did not fulfil the inclusion criteria. Among them, 239 (78.9%) were male, with a mean age of 43.7±11.7 years. The distribution of patients across surgical groups was 207 (65.7%) in the excisional group, 30 (9.5%) in the fixative group, and 78 (24.8%) in the ablative group. All groups demonstrated significant improvements in PROM scores from preoperative to postoperative assessments. However, no statistically significant differences were observed between groups at any time point for PROM scores or for changes in PROM scores across consecutive evaluations (P≥0.05 for all comparisons). Urinary retention occurred more frequently, and hospital stays were longer in the fixative group (P=0.006 and P<0.001, respectively). The excisional group had a greater need for narcotic use and longer duration of use (P=0.003 and P<0.001, respectively).Conclusion: This real-world cohort study shows that all 3 surgical approaches are effective for HD, providing comparable short-term symptomatic relief and patient satisfaction. These techniques appear equally valid treatment options, and the choice of procedure may best be individualized based on patient-specific characteristics and surgeon preference.Trial registration: ClinicalTrials.gov identifier: NCT05429060
- Open Access
- 27 November 2025
- Published by MDPI AG in Metabolites
- Vol. 15 (12) , 768
Gene Expression-Based Inference of Metabolic Signatures Reveals Distinct Molecular Profiles in Right- and Left-Sided Colon Cancer
Background/Objective: Colon cancer, the third most diagnosed cancer worldwide, is anatomically classified into right- and left-sided colon cancers based on embryonic origin and vascular supply. The aim of this study was to investigate molecular differences between patients with right- and left-sided colon cancer. Methods: In this pilot study, Blood samples from right-sided (n = 6) and left-sided (n = 6) colon cancer patients, as well as healthy controls (n = 6), were analyzed for 92 cancer-related genes via RT-qPCR. KEGG pathway analysis was performed with ShinyGO 0.82, and gene–metabolite interactions were assessed using EnrichR and MetaboAnalyst 6.0. Additionally, patients’ sociodemographic and clinical data were analyzed. Results: KEGG analysis revealed that p53, HIF-1, TNF, PI3K/Akt, MAPK, and Rap1 signaling pathways were enriched in right-sided colon cancer, whereas VEGF, HIF-1, MAPK, PI3K/Akt, Rap1, and Ras signaling pathways were implicated in left-sided colon cancer. In the gene–metabolite analysis, key metabolites identified in right-sided colon cancer included palmitic acid, adenosine triphosphate (ATP), glycerol, and adenosine diphosphate (ADP), associated with genes such as ACSL4, TP53, MAPK14, FLT1, AURKA, KDR, ERCC3, and PFKL. For left-sided colon cancer, glucose-6-phosphate (G6P), ATP, ADP, glycerol, and palmitoyl-CoA were key metabolites forming the basis of the gene–metabolite network, along with genes including G6PD, PFKL, MAPK14, FLT1, CDK4, AURKA, MAP2K1, ERCC3, TP53, WEE1, and GPD2. Conclusions: These findings highlight distinct molecular profiles between right- and left-sided colon cancers, particularly in pathways related to angiogenesis, apoptosis, ferroptosis, and fatty acid metabolism, which may inform therapeutic strategies.
- 27 November 2025
- Published by MDPI AG in Metabolites
- Vol. 15 (12) , 768
Open AccessGene Expression-Based Inference of Metabolic Signatures Reveals Distinct Molecular Profiles in Right- and Left-Sided Colon Cancer
Background/Objective: Colon cancer, the third most diagnosed cancer worldwide, is anatomically classified into right- and left-sided colon cancers based on embryonic origin and vascular supply. The aim of this study was to investigate molecular differences between patients with right- and left-sided colon cancer. Methods: In this pilot study, Blood samples from right-sided (n = 6) and left-sided (n = 6) colon cancer patients, as well as healthy controls (n = 6), were analyzed for 92 cancer-related genes via RT-qPCR. KEGG pathway analysis was performed with ShinyGO 0.82, and gene–metabolite interactions were assessed using EnrichR and MetaboAnalyst 6.0. Additionally, patients’ sociodemographic and clinical data were analyzed. Results: KEGG analysis revealed that p53, HIF-1, TNF, PI3K/Akt, MAPK, and Rap1 signaling pathways were enriched in right-sided colon cancer, whereas VEGF, HIF-1, MAPK, PI3K/Akt, Rap1, and Ras signaling pathways were implicated in left-sided colon cancer. In the gene–metabolite analysis, key metabolites identified in right-sided colon cancer included palmitic acid, adenosine triphosphate (ATP), glycerol, and adenosine diphosphate (ADP), associated with genes such as ACSL4, TP53, MAPK14, FLT1, AURKA, KDR, ERCC3, and PFKL. For left-sided colon cancer, glucose-6-phosphate (G6P), ATP, ADP, glycerol, and palmitoyl-CoA were key metabolites forming the basis of the gene–metabolite network, along with genes including G6PD, PFKL, MAPK14, FLT1, CDK4, AURKA, MAP2K1, ERCC3, TP53, WEE1, and GPD2. Conclusions: These findings highlight distinct molecular profiles between right- and left-sided colon cancers, particularly in pathways related to angiogenesis, apoptosis, ferroptosis, and fatty acid metabolism, which may inform therapeutic strategies.
- Open Access
- 9 August 2025
- Published by Springer Nature in BMC Surgery
- Vol. 25 (1) , 350
The impact of uterine manipulator assistance on intraoperative exposure and outcomes in laparoscopic rectal cancer surgery
Laparoscopic rectal surgery in female patients poses challenges due to limited pelvic space and obstructing reproductive structures. Uterine manipulators, widely used in gynecological surgery, may enhance intraoperative exposure during rectal resections, but evidence in colorectal settings is sparse. This retrospective cohort study included 40 female patients undergoing laparoscopic rectal cancer surgery between October 2024 and January 2025. Patients were divided into two groups based on the use of a uterine manipulator. Preoperative characteristics, intraoperative findings, and postoperative outcomes were compared, including exposure quality, operative time, lymph node harvest, neoadjuvant treatment response, and recovery parameters. Intraoperative exposure was significantly better in the manipulator group (VAS 8.8 ± 0.9 vs. 6.05 ± 1.5; p < 0.001). Other perioperative parameters such as operative time, bleeding, lymph node harvest, and ICU admission showed no statistically significant differences. Among patients who received neoadjuvant therapy, pathological response did not differ between groups. Hospital stay was slightly shorter and pain scores marginally higher in the manipulator group, without statistical significance. Uterine manipulators significantly improve exposure during laparoscopic rectal surgery in women without adversely affecting oncological or perioperative outcomes. They may be considered a useful adjunct in challenging pelvic dissections.
- 9 August 2025
- Published by Springer Nature in BMC Surgery
- Vol. 25 (1) , 350
Open AccessThe impact of uterine manipulator assistance on intraoperative exposure and outcomes in laparoscopic rectal cancer surgery
Laparoscopic rectal surgery in female patients poses challenges due to limited pelvic space and obstructing reproductive structures. Uterine manipulators, widely used in gynecological surgery, may enhance intraoperative exposure during rectal resections, but evidence in colorectal settings is sparse. This retrospective cohort study included 40 female patients undergoing laparoscopic rectal cancer surgery between October 2024 and January 2025. Patients were divided into two groups based on the use of a uterine manipulator. Preoperative characteristics, intraoperative findings, and postoperative outcomes were compared, including exposure quality, operative time, lymph node harvest, neoadjuvant treatment response, and recovery parameters. Intraoperative exposure was significantly better in the manipulator group (VAS 8.8 ± 0.9 vs. 6.05 ± 1.5; p < 0.001). Other perioperative parameters such as operative time, bleeding, lymph node harvest, and ICU admission showed no statistically significant differences. Among patients who received neoadjuvant therapy, pathological response did not differ between groups. Hospital stay was slightly shorter and pain scores marginally higher in the manipulator group, without statistical significance. Uterine manipulators significantly improve exposure during laparoscopic rectal surgery in women without adversely affecting oncological or perioperative outcomes. They may be considered a useful adjunct in challenging pelvic dissections.